305 related articles for article (PubMed ID: 37680614)
1. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
[TBL] [Abstract][Full Text] [Related]
2. Circulating Cell-Free DNA-Based Methylation Pattern in Saliva for Early Diagnosis of Head and Neck Cancer.
Birknerova N; Mancikova V; Paul ED; Matyasovsky J; Cekan P; Palicka V; Parova H
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230805
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review.
Schraa SJ; van Rooijen KL; Koopman M; Vink GR; Fijneman RJA
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565347
[TBL] [Abstract][Full Text] [Related]
5. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
6. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer.
Thakur K; Singh MS; Feldstein-Davydova S; Hannes V; Hershkovitz D; Tsuriel S
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440345
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma.
Yamamoto Y; Uemura M; Fujita M; Maejima K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kinouchi T; Hayashi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Nakagawa H; Nonomura N
Cancer Sci; 2019 Feb; 110(2):617-628. PubMed ID: 30536551
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
10. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
Liu W; Ji T; Zhang C; Zhou Q; Bao Z
Oral Oncol; 2022 Nov; 134():106129. PubMed ID: 36202068
[TBL] [Abstract][Full Text] [Related]
12. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
[TBL] [Abstract][Full Text] [Related]
13. Multi-Faceted Attributes of Salivary Cell-free DNA as Liquid Biopsy Biomarkers for Gastric Cancer Detection.
Swarup N; Cheng J; Choi I; Heo YJ; Kordi M; Li F; Aziz M; Chia D; Wei F; Elashoff D; Zhang L; Kim S; Kim Y; Wong DTW
Res Sq; 2023 Jul; ():. PubMed ID: 37503289
[TBL] [Abstract][Full Text] [Related]
14. Multi-faceted attributes of salivary cell-free DNA as liquid biopsy biomarkers for gastric cancer detection.
Swarup N; Cheng J; Choi I; Heo YJ; Kordi M; Aziz M; Arora A; Li F; Chia D; Wei F; Elashoff D; Zhang L; Kim S; Kim Y; Wong DTW
Biomark Res; 2023 Oct; 11(1):90. PubMed ID: 37817261
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
16. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
Thierry AR
Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
[TBL] [Abstract][Full Text] [Related]
17. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
18. Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
Pastor B; André T; Henriques J; Trouilloud I; Tournigand C; Jary M; Mazard T; Louvet C; Azan S; Bauer A; Roch B; Sanchez C; Vernerey D; Thierry AR; Adenis A
Mol Oncol; 2021 Sep; 15(9):2401-2411. PubMed ID: 33934494
[TBL] [Abstract][Full Text] [Related]
19. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma.
Kumari S; Mishra S; Anand N; Hadi R; Rastogi M; Husain N
Pathol Res Pract; 2023 Jun; 246():154489. PubMed ID: 37150134
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.
Arisi MF; Dotan E; Fernandez SV
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
